INCY vs SYK
Incyte vs Stryker Corporation — AI-powered side-by-side comparison
VS
SYK
Stryker Corporation
70
Buy
| Metric | INCY | SYK |
|---|
| AI Score |
73
|
70
|
| Price |
$120.19
|
$338.83
|
| P/E Ratio |
14.78×
|
34.86×
|
| ROE |
24.9%
|
14.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
92.6%
|
65.2%
|
| Debt / Equity |
0.01×
|
0.62×
|
| Dividend Yield |
0.0%
|
1.0%
|
| RSI (14) |
49.9
|
49.4
|
| Beta |
0.769
|
0.771
|
| Expected Upside |
—
|
+10.4%
|
AI Committee View
Current Innellis committee reasoning for INCY versus SYK.
INCY leads by 3 points.
INCY scores 73/100 (Buy) versus SYK at 70/100 (Buy).
INCY Committee View
100% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 29.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 26.9% YoY -- genuine top-line momentum — Growth
- EPS growing 80.3% YoY — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical
SYK Committee View
75% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- News sentiment is positive (+0.33 across 31 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical